Synairgen plc (LON:SNG – Get Free Report) shares crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 5.17 ($0.07) and traded as low as GBX 3.31 ($0.04). Synairgen shares last traded at GBX 3.50 ($0.05), with a volume of 580,768 shares changing hands.
Synairgen Stock Up 12.6 %
The firm has a market cap of £7.94 million, a PE ratio of -87.50 and a beta of -2.23. The company has a debt-to-equity ratio of 0.09, a quick ratio of 6.35 and a current ratio of 6.77. The company’s 50-day simple moving average is GBX 3.96 and its two-hundred day simple moving average is GBX 5.17.
Synairgen Company Profile
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; and IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease.
Recommended Stories
- Five stocks we like better than Synairgen
- Earnings Per Share Calculator: How to Calculate EPS
- Rocket Lab Stock Soars: Should Investors Chase the Rally?
- Where to Find Earnings Call Transcripts
- KB Home Slips After Earnings: What’s Next for Homebuilders?
- Basic Materials Stocks Investing
- Micron Stock Soars as AI Demand Fuels Big Q4 Earnings Beat
Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.